C1r/C1s Deficiency: A Patient Guide
At a Glance
Complete C1r/C1s deficiency is a rare inherited immune condition that can raise the risk of serious bacterial infections and autoimmune disease, including lupus and kidney inflammation. Vaccinations, preventive antibiotics when prescribed, and specialist monitoring help detect problems early.
Who this guide is for: This resource is intended for patients who have a confirmed, complete functional deficiency of C1r or C1s caused by biallelic (two) inherited genetic mutations. It does not apply to genetic carriers (who have only one mutated copy and usually no symptoms), those with isolated partial deficiencies, or those diagnosed with periodontal Ehlers-Danlos syndrome (pEDS).
C1r/C1s deficiency is an exceptionally rare genetic condition that affects the complement system, a vital part of your immune defense. In a healthy body, this system acts like a series of dominos; when it senses a threat, it triggers a cascade of proteins to destroy bacteria and clear away dead cells [1]. In people with a confirmed complete deficiency, the function of the “first dominos” of this classical pathway—the C1r and C1s proteins—is severely impaired or absent from birth. Because this condition is so rare, it is often discovered only after a patient has spent years navigating a “diagnostic odyssey” of unexplained infections or autoimmune symptoms [2][3].
Living with this deficiency involves managing a unique “dual threat” to your health. Because your immune system cannot effectively “see” and tag certain bacteria, you have an increased vulnerability to invasive infections from “encapsulated” germs, such as those that cause pneumonia and meningitis [4]. At the same time, because the classical pathway is also responsible for activating the cleanup of cellular “trash,” its absence causes debris clearance to be impaired. While this does not mean autoimmunity is inevitable, it significantly increases the risk that the immune system will eventually attack your own tissues, which can result in Systemic Lupus Erythematosus (SLE) or serious kidney inflammation known as lupus nephritis [5][2].
While there is currently no way to replace the missing proteins, the condition is manageable through a proactive, two-pronged approach. The first priority is building a defensive wall against bacteria through a rigorous schedule of specialized vaccinations and, in some cases, prophylactic antibiotics [6][7]. The second priority is long-term surveillance. By partnering with a team of specialists—including immunologists and rheumatologists—you can monitor your kidney function and immune markers closely. This individualized monitoring allows your care team to catch and treat inflammation early, helping you maintain your quality of life while navigating the complexities of this rare diagnosis [3][2].
In this guide
6 chapters
Building Your Foundation: Understanding C1r/C1s Deficiency
Learn what C1r/C1s deficiency means, including infection and lupus risks, CH50 and AH50 testing, genetic differences, vaccines, and ongoing care for patients.
Knowing the Red Flags: Infection and Emergency Care
Learn which infection warning signs need emergency care with C1r/C1s deficiency, what to tell the ER, and why fever requires prompt action in an emergency.
The Clean-up Crew: Why Deficiency Links to Autoimmunity
Learn how C1r/C1s deficiency raises autoimmune risk, including lupus nephritis, thyroid disease, and rashes, plus symptoms, monitoring, and treatment.
Solving the Puzzle: Diagnosis and Lab Reports
Learn how C1r/C1s deficiency is diagnosed: CH50, AH50, component levels, sample handling, genetic testing, and how lupus can affect complement results too.
Taking Control: Treatment and Daily Management
Learn how complement C1r/C1s deficiency is managed with vaccines, preventive antibiotics, lupus treatment, kidney monitoring, and a plan for urgent infections.
Your Long-Term Partners: Building a Care Team
Learn how to build a care team for C1r/C1s deficiency, monitor kidney and lupus risks, prepare for serious infections, and plan genetic counseling for family.
Common questions in this guide
What is complete C1r/C1s deficiency?
What is the difference between a complete deficiency and being a carrier?
Which infections are most concerning with C1r/C1s deficiency?
How can I lower my infection risk with C1r/C1s deficiency?
Can C1r/C1s deficiency lead to lupus or kidney inflammation?
Which specialists usually coordinate care for this deficiency?
Get notified when new evidence is published on complement component C1r/C1s deficiency.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (7)
- 1
Headless C1q: a new molecular tool to decipher its collagen-like functions.
Fouët G, Bally I, Signor L, et al.
The FEBS journal 2021; (288(6)):2030-2041 doi:10.1111/febs.15543.
PMID: 32869492 - 2
Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus: a case report.
Kleer JS, Skattum L, Dubler D, et al.
Frontiers in immunology 2023; (14()):1257525 doi:10.3389/fimmu.2023.1257525.
PMID: 38469558 - 3
Immunodeficiency: Complement disorders.
McMurray JC, Schornack BJ, Weskamp AL, et al.
Allergy and asthma proceedings 2024; (45(5)):305-309 doi:10.2500/aap.2024.45.240050.
PMID: 39294906 - 4
Complement C1s as a diagnostic marker and therapeutic target: Progress and propective.
Ye J, Yang P, Yang Y, Xia S
Frontiers in immunology 2022; (13()):1015128 doi:10.3389/fimmu.2022.1015128.
PMID: 36275687 - 5
Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway.
Macedo AC, Isaac L
Frontiers in immunology 2016; (7()):55 doi:10.3389/fimmu.2016.00055.
PMID: 26941740 - 6
Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020.
Mbaeyi SA, Bozio CH, Duffy J, et al.
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 2020; (69(9)):1-41 doi:10.15585/mmwr.rr6909a1.
PMID: 33417592 - 7
Clinical Outcome and Underlying Genetic Cause of Functional Terminal Complement Pathway Deficiencies in a Multicenter UK Cohort.
Shears A, Steele C, Craig J, et al.
Journal of clinical immunology 2022; (42(3)):665-671 doi:10.1007/s10875-022-01213-9.
PMID: 35084692
This guide is for informational purposes only and does not constitute medical advice. An immunologist and rheumatologist should interpret your results and personalize vaccination, infection-prevention, and kidney-monitoring plans.